Erratum: MicroRNA-34A inhibits the growth, invasion and metastasis of gastric cancer by targeting PDGFR and MET expression (Bioscience Reports DOI: 10.1042/BSR20140020);MicroRNA-34A inhibits the growth, invasion and metastasis of gastric cancer by targeting PDGFR and MET expression

Bioscience Reports

Volumn 34, Issue 3, 2014, Pages 247-256

  Peng, Yang ^a   Guo, Jin Jun ^a   Liu, Yan Min ^a   Wu, Xiao Linn ^a  

^a THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; MET; MiR 34a; PDGFR

Indexed keywords

MICRORNA 34A; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN KINASE B; SCATTER FACTOR RECEPTOR; MET PROTEIN, HUMAN; MICRORNA; MIRN34 MICRORNA, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; RNA;

ARTICLE; CANCER INHIBITION; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN TISSUE; METASTASIS INHIBITION; MIGRATION INHIBITION; MITOSIS INHIBITION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR INVASION; BIOSYNTHESIS; CELL MOTION; CLINICAL TRIAL; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; STOMACH TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; NEOPLASM INVASIVENESS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RNA, NEOPLASM; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84903607614     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR-20140020_EOC     Document Type: Erratum

References (39)

1. Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C. and Parkin, D. M. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893-2917 CrossRef PubMed
2. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31 CrossRef PubMed
3. Pietras, K., Sjoblom, T., Rubin, K., Heldin, C. H. and Ostman, A. (2003) PDGF receptors as cancer drug targets. Cancer Cell 3, 439-443 CrossRef PubMed
4. Guo, Y., Yin, J., Zha, L. and Wang, Z. (2013) Clinicopathological significance of platelet-derived growth factor B, platelet-derived growth factor receptor-beta, and E-cadherin expression in gastric carcinoma. ContempOncol (Pozn) 17, 150-155
5. MacDonald, T. J., Brown, K. M., LaFleur, B., Peterson, K., Lawlor, C., Chen, Y., Packer, R. J., Cogen, P. and Stephan, D. A. (2001) Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat. Genet. 29, 143-152 CrossRef PubMed
6. Mathey, S., Graeser, M. K., ZuEulenburg, C., Woelber, L., Trillsch, F., Jaenicke, F., MÜller, V., Milde-Langosch, K. and Mahner, S. (2013) Platelet-derived growth factor receptor beta serum concentrations during first-line therapy in ovarian cancer. Oncology 85, 69-77 CrossRef PubMed
7. Kitadai, Y., Sasaki, T., Kuwai, T., Nakamura, T., Bucana, C. D., Hamilton, S. R. and Fidler, I. J. (2006) Expression of activated platelet-derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential. Int. J. Cancer 119, 2567-2574 CrossRef PubMed
8. Mancuso, M. R., Davis, R., Norberg, S. M., O'Brien, S., Sennino, B., Nakahara, T., Yao, V. J., Inai, T., Brooks, P., Freimark, B. et al. (2006) Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J. Clin. Invest. 116, 2610-2621 CrossRef PubMed
9. Song, S., Ewald, A. J., Stallcup, W., Werb, Z. and Bergers, G. (2005) PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat. Cell. Biol. 7, 870-879 CrossRef PubMed
10. Erben, P., Horisberger, K., Muessle, B., Muller, M. C., Treschl, A., Ernst, T., Kähler, G., Ströbel, P., Wenz, F., Kienle, P. et al. (2008) mRNA expression of platelet-derived growth factor receptor-beta and C-KIT: correlation with pathologic response to cetuximab-based hemoradiotherapy in patients with rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 72, 1544-1550 CrossRef PubMed
11. Liotta, L. A. and Kohn, E. C. (2001) The microenvironment of the tumour-host interface. Nature 411, 375-379 CrossRef PubMed
12. Radinsky, R. and Fidler, I. J. (1992) Regulation of tumor cell growth at organ-specific metastases. In Vivo 6, 325-331
13. Gialeli, C., Nikitovic, D., Kletsas, D., Theocharis, A. D., Tzanakakis, G. N. and Karamanos, N. K. (2013) PDGF/PDGFR signaling and targeting in cancer growth and progression: focus on tumor microenvironment and cancer-associated fibroblasts. Curr. Pharm. Des.
14. Rana, T. M. (2007) Illuminating the silence: understanding the structure and function of small RNAs. Nat. Rev. Mol. Cell Biol. 8, 23-36 CrossRef PubMed
15. Valencia-Sanchez, M. A., Liu, J., Hannon, G. J. and Parker, R. (2006) Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 20, 515-524 CrossRef PubMed
16. Pillai, R. S., Bhattacharyya, S. N. and Filipowicz, W. (2007) Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol. 17, 118-126 CrossRef PubMed
17. Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A. et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435, 834-838 CrossRef PubMed
18. Thomson, J. M., Newman, M., Parker, J. S., Morin-Kensicki, E. M., Wright, T. and Hammond, S. M. (2006) Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 20, 2202-2207 CrossRef PubMed
19. Garofalo, M., Jeon, Y. J., Nuovo, G. J., Middleton, J., Secchiero, P., Joshi, P., Alder, H., Nazaryan, N., Di Leva, G., Romano, G. et al. (2013) MiR-34a/c-dependent PDGFR-alpha/beta downregulation inhibits tumorigenesis and enhances TRAIL-induced apoptosis in lung cancer. PLoS ONE 8, e67581 CrossRef PubMed
20. Silber, J., Jacobsen, A., Ozawa, T., Harinath, G., Pedraza, A., Sander, C., Holland, E. C. and Huse, J. T. (2012) miR-34a repression in proneural malignant gliomasupregulates expression of its target PDGFRA and promotes tumorigenesis. PLoS ONE 7, e33844 CrossRef PubMed
21. Zhang, J., Chintalgattu, V., Shih, T., Ai, D., Xia, Y. and Khakoo, A. Y. (2011) MicroRNA-9 is an activation-induced regulator of PDGFR-beta expression in cardiomyocytes. J. Mol. Cell Cardiol. 51, 337-346 CrossRef PubMed
22. Yan, D., Zhou, X., Chen, X., Hu, D. N., Dong, X. D., Wang, J., Lu, F., Tu, L. and Qu, J. (2009) MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Invest. Ophthalmol. Vis. Sci. 50, 1559-1565 CrossRef PubMed
23. Li, N., Fu, H., Tie, Y., Hu, Z., Kong, W., Wu, Y. and Zheng, X. (2009) miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett. 275, 44-53 CrossRef PubMed
24. Garofalo, M., Di Leva, G., Romano, G., Nuovo, G., Suh, S. S., Ngankeu, A., Taccioli, C., Pichiorri, F., Alder, H., Secchiero, P. et al. (2009) miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 16, 498-509 CrossRef PubMed
25. Schlessinger, J. (2000) Cell signaling by receptor tyrosine kinases. Cell 103, 211-225 CrossRef PubMed
26. Cully, M., You, H., Levine, A. J. and Mak, T. W. (2006) Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev. Cancer 6, 184-192 CrossRef PubMed
27. Thomas, G. V. (2006) mTOR and cancer: reason for dancing at the crossroads? Curr. Opin. Genet. Dev. 16, 78-84 CrossRef PubMed
28. Zhao, G., Guo, J., Li, D., Jia, C., Yin, W., Sun, R., Lv, Z. and Cong, X. (2013) MicroRNA-34a suppresses cell proliferation by targeting LMTK3 in human breast cancer MCF-7 cell line. DNA Cell Biol.
29. Ma, Y., Bao-Han, W., Lv, X., Su, Y., Zhao, X., Yin, Y., Zhang, X., Zhou, Z., MacNaughton, W. K. and Wang, H. (2013) MicroRNA-34a mediates the autocrinesignaling of PAR2-activating proteinase and its role in colonic cancer cell proliferation. PLoS ONE 8, e72383 CrossRef PubMed
30. Yang, F., Li, Q. J., Gong, Z. B., Zhou, L., You, N., Wang, S., Li, X. L., Li, J. J., An, J. Z., Wang, D. S. et al. (2013) MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment. Technol. Cancer Res. Treat.
31. Xia, J., Duan, Q., Ahmad, A., Bao, B., Banerjee, S., Shi, Y., Ma, J., Geng, J., Chen, Z., Rahman, K. M. et al. (2012) Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells. Curr. Drug Targets 13, 1750-1756 CrossRef PubMed
32. Yoshida, K., Yasui, W., Ito, H. and Tahara, E. (1990) Growth factors in progression of human esophageal and gastric carcinomas. Exp. Pathol. 40, 291-300 CrossRef PubMed
33. Birchmeier, C. and Gherardi, E. (1998) Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol. 8, 404-410 CrossRef PubMed
34. Tulasne, D. and Foveau, B. (2008) The shadow of death on the MET tyrosine kinase receptor. Cell Death Differ. 15, 427-434 CrossRef PubMed
35. Ha, S. Y., Lee, J., Kang, S. Y., Do, I. G., Ahn, S., Park, J. O., Kang, W. K., Choi, M. G., Sohn, T. S., Bae, J. M. et al. (2013) MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas. Mod. Pathol. 26, 1632-1641 CrossRef PubMed
36. Chi, F., Fu, D., Zhang, X., Lv, Z. and Wang, Z. (2012) Expression of the c-Met proto-oncogene and Integrin alpha5beta1 in human gastric cardia adenocarcinoma. Biosci. Biotechnol. Biochem. 76, 1471-1476 CrossRef PubMed
37. Feng, H., Liu, K. W., Guo, P., Zhang, P., Cheng, T., McNiven, M. A., Johnson, G. R., Hu, B. and Cheng, S. Y. (2012) Dynamin 2 mediates PDGFRalpha-SHP-2-promoted glioblastoma growth and invasion. Oncogene 31, 2691-2702 CrossRef PubMed
38. Dierov, J., Xu, Q., Dierova, R. and Carroll, M. (2002) TEL/platelet-derived growth factor receptor beta activates phosphatidylinositol 3 (PI3) kinase and requires PI3 kinase to regulate the cell cycle. Blood 99, 1758-1765 CrossRef PubMed
39. Yu, J., Deuel, T. F. and Kim, H. R. (2000) Platelet-derived growth factor (PDGF) receptor-alpha activates c-Jun NH2-terminal kinase-1 and antagonizes PDGF receptor-beta -induced phenotypic transformation. J. Biol. Chem. 275, 19076-19082 CrossRef PubMed